Equities
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)4,113.00
  • Today's Change-8.00 / -0.19%
  • Shares traded2.66m
  • 1 Year change-1.72%
  • Beta0.9146
Data delayed at least 20 minutes, as of Nov 22 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue4,263,7624,027,4783,569,006
OPERATING EXPENSES
Cost of revenue total1,426,6781,244,0721,106,846
Selling, general and admin. expenses, total1,053,819997,309886,361
Depreciation/amortization521,525542,443472,915
Unusual expense(income)181,51517,602100,290
Other operating expenses, total101,02959,43431,309
Total operating expense4,014,4903,494,1853,123,808
Operating income249,272533,293445,198
Other, net1.00--1.00
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes52,791375,090302,571
Provision for income taxes(91406)58,05272,405
Net income after taxes144,197317,038230,166
Minority interest(130)(21)(107)
Net income before extra. Items144,067317,017230,059
Total extraordinary items------
Net income144,067317,017230,059
Inc.avail. to common excl. extra. Items144,067317,017230,059
Inc.avail. to common incl. extra. Items144,067317,017230,059
EPS RECONCILIATION
Basic/primary weighted average shares1,5641,5521,564
Basic/primary eps excl. extra items92204147
Basic/primary eps incl. extra items92204147
Dilution adjustment------
Diluted weighted average shares1,5641,5701,577
Diluted eps excl. extra items92202146
Diluted eps incl. extra items92202146
COMMON STOCK DIVIDENDS
DPS - common stock primary issue188180180
Gross dividend - common stock296,078280,949282,752
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental119,535116,973122,432
SUPPLEMENTAL INCOME
Depreciation, supplemental170,339150,379132,419
Total special items181,51517,602100,290
NORMALISED INCOME
Normalized income before taxes234,306392,692402,861
Effect of special items on income taxes63,5302,72423,999
Income tax excluding impact of special items(27876)60,77696,404
Normalized income after tax262,182331,916306,457
Normalized income avail. to common262,052331,895306,350
Basic normalized EPS168214196
Diluted normalized EPS168211194
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.